Surgnova Healthcare Technologies was founded in 2015 as a high-tech company by a core founding team with decades of experience in R&D, production, marketing and other related fields in international medical giants. We specialize in minimally invasive surgery and tumor interventional treatment and are committed to be a global leader in providing total solution for minimally invasive surgery.
We own an R&D center with 10+ laboratories of electronics, machinery, optics, acoustics, robotics, animal tissue, reliability testing etc., as well as an innovation center with an operating room, an interventional room, and multifunctional training rooms in Beijing. We also own a manufacturing center over 10,000㎡with the MD GMP requirement in Emerging Industrial Cluster Area at Cixi, Zhejiang, enabling us to quickly respond to global customer needs and deliver China's high-end minimally invasive surgical total solutions to the world.
Divided into four product lines, energy surgery, surgical stapling, endoscope, and tumor ablation, our products as a total solution have accessed to dozens of countries and regions. Our products include ultrasonic scalpel system, ultrasonic surgical & electrosurgical system, ultrasonic & electrosurgical & vessel sealing system, powered endoscopic staplers, video endoscopy systems (3DHD, 3DHD Florescence, 3D4K, 3D4K Florescence), optical endoscopy systems (4K and 4K Florescence), cold light fountain power, gas insufflators, electroporation system, microwave ablation system, radiofrequency ablation system, and so on. Among them, many products have obtained CE, NMPA, FDA certifications.
Angel funding
Surgnova Healthcare Technologies (Beijing) Co., Ltd. founded
Surgnova Healthcare Technologies (Zhejiang) Co., Ltd. founded
Champion of medical team in “3315 Talent Project”
Champion of “Shanglin Yingcai Entrepreneurship Project” in Cixi City, Zhejiang Province
3000㎡ MD GMP manufacturing center put into use
A round funding
Entered “China Manufacturing 2025” project of Ningbo City, Zhejiang Province
The first 4 products passed ISO13485 audits
A+ Round funding
The first 4 products received CE Mark
NMPA Mark, 2 products
US FDA clearance, 2 products
B round funding
CE Mark, 2 products
Sales in 50+ countries
Global Master Class with world-renowned thoracic surgeon Professor Diego Gonzalez Rivas
CE Mark, 2 products
CE marks, Ultrasonic Scalpel System 7㎜ vascular closure
NMPA marks, 1 product
First IRE surgery done by Dophi™ N3000 Electroporation System in Europe
CE marks,2 products
Surgnova Oversea Bussiness Opertaing Center established in Shenzhen
NMPA marks, 1 product
NMPA marks, 1 product
C round funding
NMPA marks,1 product
NMPA marks, 1 product
Hospitalar 2022
Ranked Top100 in China's innovative medical device list for the third consecutive year,
Selected as the "specialized and special new" small and medium-sized enterprise of Ningbo in 2022
Deepeye™ 3D Video Endoscopy System was selected into the recommended catalogue of key independent innovation products in Ningbo in 2022
Dophi™ N3000 Electroporation System performed the world's first endoscopic pulsed electric field tumor ablation in the First Affiliated Hospital of Xi 'an Jiaotong University
Surgnova Beijing Innovation Center established
Innovation for Healthcare
Be a global leader in providing total solution for minimally invasive surgery by 2035
Customer Focus,Sustaniable Growth ,Entrepreneurial Spirit,Quality First,Innovation,Integrity
Local Root
Global Impact
Customer Centric
Quality First
Remain True to Our Original Aspiration
Empowered by healthcare technologies,
we grow together
Teamwork Spirit
Win-Win Cooperation
Rooted in China and facing the world, Surgnova is committed to providing the world with cutting-edge surgical systems and instruments that are easy to use, high quality, reliable and affordable, to promoting minimally invasive surgical treatments. At present, many products have obtained CE, NMPA and FDA certificates and are making inroads in many countries and regions in Europe, Latin America, Asia, the Middle East and Africa.